Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the In-vivo Ultrafiltration Coefficient and Evaluation of Performance, Hemo- and Biocompatibility- and Safety-data of High Flux Hemodialyser Diacap Pro in Patients With End Stage Renal Disease on Chronic Hemodialysis

NCT02964429 is registered in ClinicalTrials.gov with B.Braun Avitum AG as lead sponsor.

NCT NCT02964429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the In-vivo Ultrafiltration Coefficient and Evaluation of Performance, Hemo- and Biocompatibility- and Safety-data of High Flux Hemodialyser Diacap Pro in Patients With End Stage Renal Disease on Chronic Hemodialysis
Lead sponsor
B.Braun Avitum AG
Phase
Not applicable
Overall status
Completed
Start date
November 14, 2016
Completion date
December 23, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, end-stage, kidney failure,chronic, kidney insufficiency, renal insufficiency,chronic